Ductal carcinoma in situ
Conditions
Interventions
None listed
Sponsors
National Hospital Organization Nagoya Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients must meet all of the following criteria
Exclusion criteria
Exclusion criteria: Patients meeting any of the following criteria shall not be included in this study. (1) Patients with active concurrent or multiple cancers (synchronous or multiple cancers, and metachronous or multiple cancers with a disease free interval of 5 years or less. However, a history of the following pathologic stages of cancer that was completely resected shall not be included as active concurrent or multiple cancer, even if the disease free interval is less than 5 years). Gastric cancer "adenocarcinoma (general type)": Stage 0 I, Colon cancer (adenocarcinoma): Stage 0 I, Rectal cancer (adenocarcinoma): Stage 0 I, Esophageal cancer (squamous cell carcinoma, adenosquamous carcinoma, basaloid carcinoma): Stage 0, Cervical cancer (squamous cell carcinoma): Stage 0, Thyroid cancer (papillary carcinoma, follicular carcinoma): Stage I, II, III, Renal cell carcinoma (clear cell carcinoma, clear cell carcinoma): Stage I Staging classification generally follows the UICC TNM 7th edition or equivalent cancer classification guidelines. (2) Patients confirmed to be BRCA positive. (3) Patients with metastasis to regional lymph nodes. (4) Patients deemed inappropriate for participation in this study by the principal investigator or co-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-Year Cumulative Ipsilateral Breast Incidence Rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 3-Year Cumulative Contralateral Breast Incidence Rate Overall Survival Rate | — |
Countries
Japan
Contacts
Public ContactMasataka Sawaki
National Hospital Organization Nagoya Medical Center Breast Surgery, Breast Center
Outcome results
None listed